Loss of CD147 results in impaired epithelial cell differentiation and malformation of the meibomian gland by Mauris, J et al.
Loss of CD147 results in impaired
epithelial cell differentiation and
malformation of the meibomian gland
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Mauris, J, J Dieckow, S Schob, B Pulli, M P Hatton, S Jeong, A
Bauskar, E Gabison, R Nowak, and P Argüeso. 2015. “Loss of CD147
results in impaired epithelial cell differentiation and malformation
of the meibomian gland.” Cell Death & Disease 6 (4): e1726.
doi:10.1038/cddis.2015.98. http://dx.doi.org/10.1038/cddis.2015.98.
Published Version doi:10.1038/cddis.2015.98
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:23993604
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
OPEN
Loss of CD147 results in impaired epithelial cell
differentiation and malformation of the
meibomian gland
J Mauris1,8, J Dieckow1,8, S Schob2, B Pulli2, MP Hatton1,3, S Jeong4, A Bauskar5, E Gabison6, R Nowak7 and P Argüeso*,1
Meibomian gland dysfunction is a leading cause of ocular surface disease. However, little is known about the regulatory processes
that control the development and maintenance of this sebaceous gland. Here, we identify a novel function for CD147, a
transmembrane protein that promotes tissue remodeling through induction of matrix metalloproteinases, in regulating meibocyte
differentiation and activity. We found that CD147 localized along basal cells and within discrete membrane domains of
differentiated meibocytes in glandular acini containing gelatinolytic activity. Induction of meibocyte differentiation in vitro
promoted CD147 clustering and MMP9 secretion, whereas RNAi-mediated abrogation of CD147 impaired MMP9 secretion,
concomitant with a reduction in the number of proliferative cells and cytoplasmic lipids. Meibomian glands of CD147 knockout
mice had a lower number of acini in both the superior and inferior tarsal plates of the eyelids, and were characterized by loss of
lipid-filled meibocytes compared with control mice. Together, our data provide evidence showing that gelatinolytic activity in
meibocytes is dependent on CD147, and supports a role for CD147 in maintaining the normal development and function of the
meibomian gland.
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Sebacious glands are holocrine lobulated structures found
over most surfaces of the human body.1 Traditionally thought
to synthesize and secrete lipids to promote barrier function of
the skin against environmental insult, emerging research has
provided evidence of their involvement in additional functions
such as regulation of immunological functions and inflamma-
tory processes.2 Meibomian glands constitute a specialized
form of sebaceous gland located inside the tarsal plate of the
eyelids, where they promote stability of the tear film and
prevent ocular surface dryness.3 Impairment in sebaceous
gland function has been associated with a variety of diseases,
which in the eye includemeibomian gland dysfunction, a disease
affecting millions of people worldwide.3–5 Complete absence
of meibomian glands has been reported in patients with
ectodermal dysplasia, ectrodactyly, and clefting syndrome
and anhidrotic ectodermal dysplasia, rare congenital condi-
tions characterized by abnormal ectoderm development.6
The structure and secretory composition of the meibomian
glands has been extensively studied, both under physiological
and pathological conditions. By comparison, little is known
about the molecular mechanisms that regulate meibomian
gland development and maintenance.7 The meibomian gland,
as any other holocrine gland, undergoes constant self-renewal.
Critical to maintain tissue architecture is the extracellular
matrix, a major component of the cellular microenvironment.8
Alteration of the extracellular matrix occurs when radical
remodeling is needed, such as during organ development and
tissue homeostasis, and is associated with changes in cell
proliferation and differentiation. The most significant enzymes
involved in the degradation and remodeling of the extracellular
matrix in tissues are zinc-dependent matrix metalloprotei-
nases (MMPs) that include gelatinase B or MMP9. Both three-
dimensional culture models and genetic manipulations of mice
carrying gain- or loss-of-function alleles of MMPs have shown
a critical role for MMPs in gland development and branching
morphogenesis.9,10 At the ocular surface, the homeodomain
transcription factor Barx2 has been shown to control gland
morphogenesis by inducing the expression of MMPs.11
However, the exact mechanism underlying the expression of
MMPs in ocular glands is not yet clear.
The production and activation of MMPs are tightly regulated
by complex mechanisms that include the extracellular matrix
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metalloproteinase inducer CD147 (also known as basigin in
the mouse), a glycosylated type I transmembrane protein
known to induce cell migration and invasion.12,13 CD147
activity was initially discovered in 1982 in a series of studies
showing that co-culture of tumor cells and fibroblasts lead to
stimulation of MMP1 production.14,15 Since then, additional
evidence has demonstrated that homophilic CD147 oligomer-
ization induces MMP production, both through heterotypic and
homotypic cell interactions.13 The molecular weight of CD147
is highly variable (31–65 kDa) because of heterogeneous N-
glycosylation, with the most highly glycosylated forms
functioning to induce MMP production.16 Importantly, CD147
has been proposed as a modulator of MMP expression during
development and cell differentiation.17 In support of this
hypothesis are findings showing strong induction of CD147
in basal and suprabasal cells during skin organogenesis.18
Here, we analyze the distribution of CD147 in the human
meibomian gland and its contribution to MMP production. We
find that CD147 is expressed in basal epithelial cells andwithin
discrete membrane domains of differentiated meibocytes, and
that it regulates MMP9 biosynthesis during meibocyte
differentiation. Moreover, we show that CD147 modulates
meibocyte proliferation and lipid biosynthesis. Finally, we use
CD147 knockout mice as a model system to examine the
relevance of these findings to meibomian gland formation and
activity in vivo.
Results
CD147 and gelatinolytic activity localize to acinar
structures in human meibomian glands. To determine
whether CD147 modulates the expression of MMPs in meibo-
mian glands, we first evaluated the distribution of CD147 in
upper eyelids of human donors by immunofluorescence
microscopy. Meibomian glands are composed of clusters of
secretory acini that are arranged circularly around a long
central duct and connected to it by short ductules.19 By
immunofluorescence, CD147 localized to basal cells at the
peripheral margin of secretory acini and to the multilayered
squamous epithelium of the ductule (Figure 1a). While basal,
proliferating meibocytes stained distinctly for CD147, the
signal decreased towards differentiated mature and hyper-
mature meibocytes (Figure 1b). This central region was
characterized by patchy or discontinuous staining of CD147
along the cell membrane (Figure 1b, inset). The presence of
CD147 mRNA in acinar structures was demonstrated by laser
capture microdissection of meibomian gland tissue using RT-
PCR, and further confirmed by cDNA sequencing (Figure 1c).
The presence of proliferating basal acinar cells was demon-
strated by staining for proliferating cell nuclear antigen
(PCNA), a marker of growing cells entering the early S
phase of the cell cycle (Figure 1d).20
In order to evaluate the role of CD147 in promoting MMPs in
human meibocytes, we then examined the distribution of
gelatinolytic activity throughout the meibomian gland. In situ
gelatin zymography revealed localization of gelatinolytic
activity primarily in secretory acinar structures within the
meibomian gland (Figure 1e). The activity was detected in
basal and intermediate cell layers, representing proliferating
and mature meibocytes, respectively, and decreased towards
the disintegrating zone, located at the transition of the acinus
to the ductule (Figure 1f).
CD147 promotes MMP9 biosynthesis during meibocyte
differentiation. To test a direct link between CD147 and
MMP9 biosynthesis during meibocyte differentiation, we took
advantage of an experimental cell culture model system
using hTERT-immortalized human meibomian gland epithelial
cells.21 In this system, confluent cells in serum-free media
proliferate and have cobblestone-like morphology, whereas
addition of serum induces differentiation and stratification
(Figure 2a).21 Immunolocalization studies in cells grown in
serum-free media revealed continuous pericellular distribu-
tion of CD147 throughout the cell culture (Figure 2a). Under
these conditions, MMP9 had preferentially an intracellular
distribution. Interestingly, induction of differentiation and
stratification in the cell culture was characterized by patchy
or discontinuous staining of CD147 along the cell membrane,
reminiscent of the staining observed in mature meibocytes
within acinar structures in vivo. Moreover, addition of serum
to the cell culture resulted in CD147 colocalization with
areas that were positive for MMP9 staining (Figure 2a),
suggesting a link between the two proteins during meibocyte
differentiation.
To determine whether CD147 was responsible for MMP9
biosynthesis and secretion in human meibocytes in vitro, we
silenced CD147 using small interfering RNA (siRNA). As
evidenced by immunoblot, addition of serum to cell cultures
increased the levels of MMP9 in whole cell lysates (Figure 2b).
The levels of CD147, on the other hand, decreased upon
serum-induced differentiation, concomitant to the observation
in Figure 2a showing discontinuous staining of CD147 along
the cell membrane. Importantly, MMP9 biosynthesis was
impaired in differentiated cells following treatment with siRNA
targeting CD147 compared with scramble control (Figure 2c),
suggesting an important role for CD147 expression and
clustering along the cell membrane of differentiated meibo-
cytes in promoting MMP9 biosynthesis.
CD147 regulates meibocyte proliferation and lipid bio-
synthesis. In addition to its role in mediating MMP biosynth-
esis, data published so far suggest that CD147 also has
additional functions that include promotion of cellular pro-
liferation.22,23 Therefore, we examined the hypothesis that
CD147 interferes with the cell cycle progression of human
meibocytes. For these experiments, we used bromodeoxyur-
idine (BrdU), a pyrimidine analog that incorporates into newly
synthesized DNA of actively proliferating cells. As shown in
Figure 3a, incorporation of BrdU decreased after treatment of
human meibocytes with siRNA targeting CD147, supporting
the concept that CD147 positively regulates cell proliferation
in human meibocytes. Consistent with reduced BrdU
incorporation, we also observed a decrease in PCNA in
protein lysates of cells treated with CD147 siRNA. Further,
the intracellular accumulation of neutral lipids was impaired
following abrogation of CD147 (Figure 3b), suggesting that
CD147 expression also contributes to promote meibocyte
differentiation.
Role of CD147 in the meibomian gland
J Mauris et al
2
Cell Death and Disease
Bsg− /− mice show morphological and functional
alterations in the meibomian glands. Homozygous knock-
out mice (Bsg− /−) and age-matched littermate controls (WT)
were examined to determine the relevance of CD147
expression to meibomian gland formation and activity
in vivo. Analysis of meibomian gland morphology by light
microscopy revealed marked differences between Bsg− /−
and WT mice in both the superior and inferior tarsal plates
(Figure 4a). In WT mice, distinct clusters of secretory acini
were observed throughout the length of the tarsal plates in
the upper and lower lids. By comparison, secretory acini in
meibomian glands of Bsg− /− mice were poorly developed
Figure 1 CD147 and gelatinolytic activity localize to acinar structures in human meibomian glands. (a) Immunofluorescence microscopy of a human eyelid showing CD147
localization (green) to basal cells at the peripheral margin of secretory acini and to the multilayered squamous epithelium of the ductule. Nuclei were counterstained using DAPI
(blue). (b) Within the acinus, CD147 staining decreased towards differentiated mature and hypermature meibocytes. This central region was characterized by patchy staining of
CD147 along the cell membrane (inset). (c) Laser capture microdissection (LCM) and RT-PCR analysis demonstrating CD147 mRNA in acinar structures of meibomian gland
tissue. Representative micrographs are shown before (left) and after (right) microdissection. Cultures of human corneal epithelial cells were used as positive control.
(d) Immunofluorescence microscopy of a human eyelid showing PCNA (red) localization to basal acinar cells. CD147 was labeled in green. Nuclei were counterstained using
DAPI (blue). (e) In situ gelatin zymography showing localization of gelatinolytic activity in secretory acinar cells of the meibomian gland. (f) Within the acinus, activity was detected
in basal and mature meibocytes, and decreased towards the disintegrating zone. Acinus (a), basal cell (b), ductile (d), epidermis (e), mature cell (m), hypermature cell (h). Scale
bars, 300 μm (a), 10 μm (d), 200 μm (e), 100 μm (b and f)
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and appeared smaller in size (Figures 4b and c). Importantly,
cells in secretory acini of Bsg− /− mice failed to produce lipid
vesicles as shown by Oil Red O staining (Figure 5a). In these
experiments, the area of Oil Red O staining in tarsal plates of
Bsg− /− mice decreased by 76% and 84% in the superior and
inferior lids, respectively (Figure 5b). These results indicate
that CD147 expression is necessary and sufficient to induce
meibocyte differentiation.
Discussion
Despite the importance of the meibomian glands in promoting
ocular surface health and integrity, research into molecular
mechanisms regulating meibocyte formation and maturation
is still limited. It is now well established that MMP biosynthesis
is crucial for the development, differentiation, and activity of
epithelial tissues.8,9,24 Here, we find that the metalloprotei-
nase inducer CD147 is produced by secretory acini of human
meibomian glands, in areas associated with high gelatinolytic
activity. Notably, we identify CD147 as a novel regulator of
MMP biosynthesis, cell proliferation, and cell differentiation in
an experimental cell culture model with human meibocytes. In
addition, we show that targeted deletion of CD147 in mice
causesmeibomian glandmalformation and impairs meibocyte
function in vivo.
MMPs play essential roles as mediators of change and
physical adaptation in tissues, whether developmentally
regulated, environmentally induced, or disease-associated.9
In line with previous reports in glandular tissues, recent data
have demonstrated that regulation of MMP expression in
ocular glands is important in the remodeling of the extracellular
matrix during branching morphogenesis.11,25,26 Further, con-
trol of MMP activity is known to be critical to the maintenance
of ocular surface health, and an improper balance of MMPs
has been associated with inflammation and disease.27 To our
knowledge, reports describing the distribution of gelatinolytic
Figure 2 CD147 promotes MMP9 biosynthesis during meibocyte differentiation. (a) By phase-contrast microscopy, cultured meibocytes in serum-free media proliferated and
had cobblestone-like morphology, whereas addition of serum induced differentiation and stratification. When grown in serum-free media, CD147 had a continuous pericellular
distribution (red) while MMP9 (green) was primarily intracellular. Addition of serum promoted a discontinuous pattern of CD147 staining along the cell membrane that colocalized
with areas that were positive for MMP9 (inset). Nuclei were counterstained using DAPI (blue). Scale bars, 200 μm (phase), 100 μm (immunofluorescence). (b) Immunoblot
showing increased levels of MMP9 in whole cell lysates after addition of serum to cell cultures. Levels of CD147, on the other hand, decreased upon serum-induced differentiation.
Data shown are representative of two independent experiments and the experiments were performed at least in duplicate (mean± S.D.; **Po0.01, Student’s t-test).
(c) Biosynthesis of MMP9 decreased in differentiated meibocytes following abrogation of CD147 using siRNA. Data shown are representative of two independent experiments
and the experiments were performed at least in duplicate (mean±S.D.; *Po0.05, Student’s t test)
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activity in the meibomian gland are absent. In the present
study, we demonstrate by in situ zymography that MMPactivity
localizes to secretory acinar structures within the meibomian
gland, both in proliferating and mature meibocytes, and
decreases towards the disintegrating zone. These results
showing gelatinolytic activity in vivo are consistent with previous
data showing MMP expression in cultures of lipid-producing
cells, including human meibocytes.28,29 Importantly, they
support a role for MMPs in regulating cellular homeostasis in
the meibomian gland.
Numerous studies with experimental models have identified
CD147 as one of the most important surface proteins
responsible for the induction of MMPs.12 Ample evidence
indicates that CD147 stimulates MMP synthesis through self-
association, involving both heterotypic and homotypic cell–cell
interactions.13 Although the mechanism by which CD147
regulates MMPs remains elusive, formation of CD147-based
complexes, in which CD147 associates with additional
proteins such as integrins, is known to modulate signal-
ing and gene transcription, leading to distinct cellular
responses.30 Our immunofluorescence staining of the human
meibomian gland showed discrete clustering of CD147 along
the cell membrane of differentiated meibocytes in glandular
acini, which suggests self-association of CD147 in areas
associated to gelatinolytic activity. Consistent with this
hypothesis, we found that induction of meibocyte differentia-
tion using serum-containing media in cell culture promoted
CD147 clustering and stimulated MMP9 biosynthesis and
secretion. Further, we demonstrated that supression of
CD147 expression by siRNA reduced the levels of MMP9 in
differentiated human meibocytes. Taken together, these
results suggest that CD147 expression and clustering is
involved in promoting gelatinolytic activity in differentiated
meibocytes.
In addition to its role as an inducer of MMP biosynthesis,
CD147 was recently found to be involved in the regulation of
cell proliferation in tumor epithelial cells both in vitro and
in vivo.23,31,32 In this investigation, we used BrdU incorporation
and PCNA immunoblotting to assess the effects of CD147
expression on meibocyte proliferation in vitro. Consistent with
previous reports, knockdown of CD147 reduced the prolif-
erative activity of cells in culture. Moreover, differentiation was
impaired as shown by decreased lipid accumulation in human
meibocytes following CD147 abrogation. Histologic analysis
of eyelids from Bsg− /−mice also revealed that their meibomian
glands were poorly developed and appeared smaller in size. In
addition, the ability to produce lipids in the tarsal plated of Bsg− /−
mice was impaired compared with age-matched littermate
controls. These findings strongly indicate that CD147 reg-
ulates the normal development and function of the meibomian
gland. Lipids produced by the meibomian glands are a major
component of the ocular surface, where they prevent tear
evaporation and contribute to maintain a wet-surfaced
phenotype.19,33 Reduced quantity of lipids and increased
protease activity on the ocular surface has been observed in
patients with meibomian gland dysfunction.4,34 Further,
complete absence of meibomian glands has been reported
in EEC syndrome and anhidrotic ectodermal dysplasia.6 It is
tempting to speculate that CD147 has a role in the pathogen-
esis of patients suffering from these pathologies, but any
hypothetical involvement remains to be determined.
To our knowledge, this is the first study to explore the role of
CD147 in normal development and function of sebum-
producing epithelial cells. Our findings indicate that CD147
plays a role in the induction and secretion of MMP9 during
meibocyte differentiation. We find that decreased expression
of CD147 reducesmeibocyte cell proliferation and the ability to
synthesize lipids. Finally, we demonstrate that the loss of
Figure 3 CD147 regulates meibocyte proliferation and lipid biosynthesis.
(a) BrdU incorporation was used to assess cell cycle progression. As shown by flow
cytometry, treatment of human meibocytes grown in serum-free media with siRNA
targeting CD147 led to a 30% decrease in the incorporation of BrdU compared with
scramble control. Each of the samples was analyzed in sixtuplicate (mean± S.D.;
**Po0.01, Mann Whitney test). Immunoblot experiments demonstrate decreased
biosynthesis of CD147 and a 60% decrease in PCNA in human meibocytes grown in
serum-free media following abrogation of CD147 using siRNA. Experiments were
performed in triplicate (mean±S.D.; *Po0.05, Student’s t-test). FSC, forward
scatter. (b) Abrogation of CD147 using siRNA impaired intracellular accumulation of
neutral lipids in differentiated meibocytes. Representative images for each condition
are shown in the upper panel. Experiments were performed in triplicate (mean± S.D.;
*Po0.05, Student’s t-test). Immunoblot experiments demonstrate decreased
biosynthesis of CD147 in differentiated meibocytes following abrogation of CD147
using siRNA. Scale bars, 20 μm
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CD147 results in impaired differentiation and malformation of
the meibomian gland in vivo. We therefore propose a model
where CD147 promotes meibomian gland turnover by
regulating proteolytic activity and meibocyte maturation.
Materials and Methods
Cell culture and human tissue. Telomerase-transformed human meibo-
mian gland epithelial cells were grown as previously described.21 Briefly, cells were
grown in keratinocyte serum-free medium (Life Technologies, Carlsbad, CA, USA)
to achieve confluence, followed by DMEM/F12 (Sigma-Aldrich, St Louis, MO, USA)
supplemented with 10% calf serum for 7 days to promote differentiation. Experiments
using human specimens were approved by the Schepens Eye Research Institute
Institutional Review Board (IRB#2011-027). These studies were performed using
discarded and deidentified human tissue and were deemed to have IRB exempt
status not requiring informed consent. Discarded human eyelid tissue was collected
from a donor who underwent ectropion repair and immediately frozen in optimal
cutting temperature compound (OCT) for sectioning using a cryostat.
Immunofluorescence. Sections of human eyelid tissue in OCT (6-μm thick)
were fixed with ice-cold methanol for 10 min and baked overnight at 37 °C.
Following hydration in phosphate-buffered saline (PBS) for 10 min, sections were
blocked in 3% bovine serum albumin in PBS for 30 min. After this, sections were
incubated with primary anti-CD147 (clone HIM6,35 1 : 50; BioLegend, San Diego,
CA, USA), anti-PCNA (1 : 100; Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA), or anti-MMP9 (1 : 50; Abcam, Cambridge, MA, USA) antibodies in 3% BSA in
PBS for 1 h at room temperature in a moist chamber. Incubation with primary
antibodies was routinely omitted in control experiments. After rinsing with PBS,
three times for 2 min each, the corresponding secondary antibodies were applied for
1 h at room temperature. Slides were then rinsed, mounted in VectaShield mounting
medium containing DAPI (Vector Laboratories, Burlingame, CA, USA), and
observed under a fluorescence microscope (Nikon Eclipse E-400; Tokyo, Japan).
Laser capture microdissection. Sections of human eyelid tissue in OCT
(6-μm thick) were placed on Arcturus PEN Membrane Slides (Applied Biosystems,
Foster City, CA, USA), fixed in 70% ethanol, and stained with Hematoxylin/Eosin
(Sigma-Aldrich Co.) under RNase-free conditions. Meibomian gland secretory acini
Figure 4 Meibomian glands in Bsg− /− mice show altered morphology. (a) Histological analysis of toluidine blue-stained sections of tarsal plates (dashed rectangles) in the
upper and lower eyelids. WT control mice (WT; n= 4) contained clusters of secretory acini (arrows) throughout the length of the superior and inferior tarsal plates. By comparison,
secretory acini in meibomian glands of Bsg− /− mice (n= 4) were poorly developed and appeared smaller in size. The arrowhead indicates the terminal position of the central
meibomian duct at the eyelid margin. The lower panel contains magnified images of secretory acini areas. Scale bars, 50 μm. (b and c) Quantification of the total area and number
of secretory acini per section in the superior and inferior tarsal plates of WT and Bsg− /− mice. A total of 25–50 sections were analyzed per eyelid sample (mean±S.D.;
**Po0.01, ***Po0.001, Student’s t-test)
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were captured using a laser microdissection microscope (Model AS LMD; Leica,
Wetzlar, Germany) and subjected to total RNA extraction.
Nucleic acid extraction and RT-PCR. Total RNA was isolated from laser-
captured sections of meibomian gland acini using the RNeasy Micro Kit (Qiagen
Sciences, Germantown, MD, USA), and 1 μg of total RNA was used to make cDNA
using the iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA, USA)
following the manufacturer's instructions. PCR reactions were performed with 0.8 μl
cDNA using the Advantage 2 PCR kit (Clontech Laboratories, Inc., Mountain View,
CA, USA) and published CD147 primers.36 GAPDH primers (Applied Biosystems)
were used as an internal control. Cultures of human corneal epithelial cells served
as positive control. For CD147 amplification in laser-captured sections, the PCR
reaction included an initial cycle of 95 °C for 5 min; 45 cycles of denaturation (95 °C
for 30 s), annealing (64 °C for 30 s), and elongation (72 °C for 30 s); and a final
extension cycle of 72 °C for 5 min. The PCR products (10 μl) were analyzed
electrophoretically in 1% (wt/vol) agarose gels containing ethidium bromide and
visualized under UV light. To verify the identity of the CD147 PCR product, the band
in the agarose gel was excised, and the extracted DNA was sequenced at the DNA
Core Facility of Massachusetts General Hospital, Boston, MA, USA.
Transfection of siRNA. Depletion of CD147 in cultures (6-well plates) of both
proliferating and differentiated meibocytes was achieved using Silencer Select Pre-
designed siRNA (ID215973; Ambion, Austin, TX, USA). Silencer Select Negative
Control siRNA (ID4390843) was used as a scrambled sequence. For knockdown in
proliferating cells, cultures grown to 60–70% confluence were transfected by
6-h incubation with 500 nM siRNA in Lipofectamine 2000 (1 μl/100 mm2, Life
Technologies) dissolved in Opti-MEM reduced-serum medium (Life Technologies).
After transfection, the cells were incubated in serum-free medium lacking antibiotics
for 18 h, followed by antibiotic-containing serum-free medium for an additional 48 h.
For knockdown in differentiated cells and MMP analyses, cultures were grown to
confluence and allowed to differentiate in serum-containing medium for 7 days.
Thereafter, cells were transfected on days 7, 8, and 9 by 6-h incubation with 500 nM
siRNA in Lipofectamine 2000 dissolved in serum-containing medium lacking
antibiotics. After each transfection, cells were incubated in serum-containing
medium lacking antibiotics for an additional 18 h. Cells in both proliferating and
differentiated conditions were thoroughly washed in PBS and incubated in 1 ml
serum-free medium for 3 h before collecting the supernatants and cell extracts. For
knockdown in differentiated cells and LipidTOX analyses, cultures were transfected
twice, once at 100% confluence, and then 3 days post confluence, and allowed to
differentiate in serum-containing medium for 7 days. For each transfection, cells
were treated with 500 nM siRNA in Opti-MEM reduced-serum medium in
Lipofectamine 2000 for 6 h. Cultures were then incubated for 18 h with serum-
containing medium lacking antibiotics. After transfections, the media was switched
to serum-containing medium with antibiotics.
Immunoblotting. Protein from cell cultures was extracted using RIPA buffer
(150 μM NaCl, 50 μM Tris-HCl, pH 8.0, 1% NP-40, 0.5% deoxycholate, 0.1% SDS)
supplemented with Complete Protease Inhibitor Cocktail (Roche Diagnostics, Indian-
apolis, IN, USA). After homogenization with a pellet pestle, the protein cell extracts were
centrifuged at 12 000 × g for 45 min, and the protein concentration of the supernatant
determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Rockford,
IL, USA). Proteins in cell lysates (40 μg) were resolved in 10% SDS-PAGE,
and electroblotted onto nitrocellulose membranes (Bio-Rad). Membranes were then
incubated with primary antibodies to CD147 (clone A-12,37 1 : 3000, Santa Cruz
Biotechnology, Inc.), MMP9 (1 : 1500, Abcam), PCNA (1 : 3000, Santa Cruz
Biotechnology, Inc.) or GAPDH (1 : 3000, Santa Cruz Biotechnology, Inc.) in TTBS
supplemented with 5% nonfat dry milk overnight at 4 °C, followed by the appropriate
secondary antibodies coupled to horseradish peroxidase (1 : 5000, Santa Cruz
Biotechnology, Inc.). Peroxidase activity was detected on HyBlot CL autoradiography film
(Denville Scientific, Inc., Plainfield, NJ, USA) using SuperSignal West Pico
Chemiluminiscence substrate (Thermo Scientific). Immunoblots were quantified using
ImageJ software.
In situ zymography. In situ gelatinase activity was measured using the
EnzCheck Gelatinase Assay kit (Molecular Probes, Carlsbad, CA, USA) following
the manufacturer’s instructions. Briefly, sections of human eyelid tissue in OCT
(6-μm thick) were incubated with 2 μg DQ-gelatin-fluorescein isothiocyanate
overnight at 37 °C, washed with PBS and mounted using coverslips and VectaShield
mounting medium containing DAPI (Vector Laboratories). Sections were then
examined under a fluorescence microscope and photographed. As a negative
control for in situ zymography, frozen cryostat sections were incubated with reaction
buffer supplemented with 40 μM 1,10-phenanthroline to inhibit metalloproteinases.
Bromodeoxyuridine labeling. BrdU incorporation and flow cytometry
analysis were used to assess cell cycle progression. Cultures of human meibocytes
in serum-free media were stained using the APC BrdU Flow Kit (BD Pharmingen,
San Jose, CA, USA) according to the manufacturer’s protocol. Briefly, cells were
harvested 12 h following addition of 10 μM BrdU into the culture media. Following
fixation and permeabilization, incorporated BrdU was exposed by treatment with
DNase for 1 h at 37 °C. Cells were subsequently stained with APC-anti-BrdU
antibody (1 : 50) and analyzed on a BD LSRII flow cytometer (Beckton Dickenson,
San Jose, CA, USA). Cells from the same population that were not exposed to BrdU
were used as a negative staining control to determine background-staining levels for
the anti-BrdU monoclonal antibody.
Mouse tissue. Animals used in this research were maintained in accordance
with the guidelines of the Institutional Animal Care and Use Committee at the
University of Illinois. The WT C57BL6/J and basigin-null (Bsg− /−) mice38,39 were
housed under temperature- and light-controlled conditions (12 h light: 12 h dark)
Figure 5 Bsg− /− mice show functional alterations in the meibomian glands.
(a) Oil Red O staining shows abundant lipid deposition in the superior and inferior
tarsal plates of the meibomian glands in WT control mice (WT) as compared with
Bsg− /− mice. (b) Quantification of areas of Oil Red O staining per tarsal plate in WT
(n= 3) and Bsg− /− (n= 3) mice using ImageJ. A total of 16–32 sections were
analyzed per eyelid sample (mean± S.D.; *Po0.05, Student’s t-test)
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with free access to food and water. Adult mice (10–14-months old) were
anesthetized by isoflurane inhalation (Attane, Minrad, Bethlehem, PA, USA). For
histological studies, mice heads were fixed in 1% glutaraldehyde in PBS. Eyes with
intact lids were then excised and embedded in methacrylate. Semithin sections
(3-μm thick) were stained with toluidine blue for light microscopy. For lipid staining
and fluorescence microscopy, mice heads were fixed in 2% PBS-buffered formalin
and the excised eyes with intact lids embedded in OCT. All mouse tissue was
sectioned at the central eyelid position. Photomicrographs were taken using Nikon
Eclipse E-800 microscope (Nikon Instruments, Melville, NY, USA).
LipidTOX green and oil red o staining. For lipid staining in cell culture,
cells grown on glass chamber slides (Nalgene Nunc International, Naperville, IL,
USA) were washed with PBS and fixed in 4% paraformaldehyde for 30 min. Slides
were incubated in LipidTOX Green neutral lipid stain (Invitrogen, Grand Island, NY,
USA) in a moist chamber for 30 min at room temperature. Slides were then mounted
in VectaShield mounting medium containing DAPI (Vector Laboratories), and
observed under a fluorescence microscope. Quantification of lipid staining was
performed using imageJ software (NIH, Bethesda, MD, USA). For lipid staining in
mouse tissue, cryosections (10-μm thick) were air-dried, rinsed in 60% isopropanol,
and stained with 0.3% Oil Red O (Fisher Biotec, Wembley, WA, Australia) for 15 min
at room temperature. The sections were rinsed again and mounted in VectaShield
mounting medium for light microscopy.
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